Corel Partners with Leading BioTech Institute for Cancer Research Initiative

Corel Pharmaceuticals announces a five-year strategic partnership with a leading biotech research institute to advance oncology research. The collaboration will focus on next-generation immunotherapy treatments for rare cancers, accelerating drug discovery timelines and improving patient outcomes through combined research expertise.